Form 8-K - Current report:
SEC Accession No. 0001193125-18-082582
Filing Date
2018-03-14
Accepted
2018-03-14 17:23:57
Documents
7
Period of Report
2018-03-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d550834d8k.htm 8-K 29573
2 EX-4.1 d550834dex41.htm EX-4.1 323925
3 EX-4.2 d550834dex42.htm EX-4.2 308654
4 EX-4.4 d550834dex44.htm EX-4.4 112393
5 EX-4.5 d550834dex45.htm EX-4.5 327804
6 EX-4.6 d550834dex46.htm EX-4.6 310496
7 EX-4.8 d550834dex48.htm EX-4.8 119294
  Complete submission text file 0001193125-18-082582.txt   1533442
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 18690340
SIC: 2834 Pharmaceutical Preparations